Both STAT2 and STAT3 activation were involved in IFN-β-induced decrease of TNF-α levels in LPS treated CF, as demonstrated by si-STAT2 and si-STAT3 prevention of TNF-α decrease. The gene discussed is STAT2; the disease is cystic fibrosis.